Final results of a phase II study of nab-paclitaxel, bevacizumab, and gemcitabine as first-line therapy for patients with HER2-negative metastatic breast cancer
Titel:
Final results of a phase II study of nab-paclitaxel, bevacizumab, and gemcitabine as first-line therapy for patients with HER2-negative metastatic breast cancer
Auteur:
Lobo, Christopher Lopes, Gilberto Baez, Odalys Castrellon, Aurelio Ferrell, Annapoorna Higgins, Connie Hurley, Erin Hurley, Judith Reis, Isildinha Richman, Stephen Seo, Pearl Silva, Orlando Slingerland, Joyce Tukia, Keleni Welsh, Catherine Glück, Stefan